Frontiers | MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients


















































































Download






































Disclaimer:

This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

Click here for Source link (https://www.frontiersin.org/)

Loading